BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 15993494)

  • 1. Antibodies induced by ganglioside-mimicking Campylobacter jejuni lipooligosaccharides recognise epitopes at the nodes of Ranvier.
    Moran AP; Annuk H; Prendergast MM
    J Neuroimmunol; 2005 Aug; 165(1-2):179-85. PubMed ID: 15993494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guillain-Barré syndrome- and Miller Fisher syndrome-associated Campylobacter jejuni lipopolysaccharides induce anti-GM1 and anti-GQ1b Antibodies in rabbits.
    Ang CW; De Klerk MA; Endtz HP; Jacobs BC; Laman JD; van der Meché FG; van Doorn PA
    Infect Immun; 2001 Apr; 69(4):2462-9. PubMed ID: 11254608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenesis of Guillain-Barré and Miller Fisher syndromes subsequent to Campylobacter jejuni enteritis.
    Yuki N
    Jpn J Infect Dis; 1999 Jun; 52(3):99-105. PubMed ID: 10507987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Campylobacter jejuni enteritis and Guillain-Barré syndrome].
    Yuki N
    Rinsho Byori; 1999 Aug; 47(8):713-8. PubMed ID: 10511801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibodies to gangliosides in Guillain-Barré syndrome: specificity and relationship to clinical features.
    Gregson NA; Koblar S; Hughes RA
    Q J Med; 1993 Feb; 86(2):111-7. PubMed ID: 8464986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Campylobacter jejuni lipopolysaccharides from Guillain-Barré syndrome patients induce IgG anti-GM1 antibodies in rabbits.
    Ang CW; Endtz HP; Jacobs BC; Laman JD; de Klerk MA; van der Meché FG; van Doorn PA
    J Neuroimmunol; 2000 May; 104(2):133-8. PubMed ID: 10713352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ganglioside-induced antiganglioside antibodies from a neuropathy patient cross-react with lipopolysaccharides of Campylobacter jejuni associated with Guillain-Barré syndrome.
    Neisser A; Schwerer B; Bernheimer H; Moran AP
    J Neuroimmunol; 2000 Jan; 102(1):85-8. PubMed ID: 10626671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipopolysaccharides in the development of the Guillain-Barré syndrome and Miller Fisher syndrome forms of acute inflammatory peripheral neuropathies.
    Prendergast MM; Moran AP
    J Endotoxin Res; 2000; 6(5):341-59. PubMed ID: 11521055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GM1 antibody in Guillain-Barre syndrome after Campylobacter jejuni infection.
    Tang J; Yuan J; Hao H
    Chin Med J (Engl); 1995 Apr; 108(4):262-4. PubMed ID: 7789212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Axonal Guillain-Barré syndrome: relation to anti-ganglioside antibodies and Campylobacter jejuni infection in Japan.
    Ogawara K; Kuwabara S; Mori M; Hattori T; Koga M; Yuki N
    Ann Neurol; 2000 Oct; 48(4):624-31. PubMed ID: 11026446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum anti-GQ1b IgG antibodies recognize surface epitopes on Campylobacter jejuni from patients with Miller Fisher syndrome.
    Jacobs BC; Endtz H; van der Meché FG; Hazenberg MP; Achtereekte HA; van Doorn PA
    Ann Neurol; 1995 Feb; 37(2):260-4. PubMed ID: 7531419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ganglioside GM1 mimicry in Campylobacter strains from sporadic infections in the United States.
    Nachamkin I; Ung H; Moran AP; Yoo D; Prendergast MM; Nicholson MA; Sheikh K; Ho T; Asbury AK; McKhann GM; Griffin JW
    J Infect Dis; 1999 May; 179(5):1183-9. PubMed ID: 10191221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Campylobacter jejuni enteritis and Guillain-Barré syndrome].
    Yuki N
    Rinsho Shinkeigaku; 1999 Jan; 39(1):17-8. PubMed ID: 10377788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular mimicry between gangliosides and lipopolysaccharides of Campylobacter jejuni isolated from patients with Guillain-Barré syndrome and Miller Fisher syndrome.
    Yuki N
    J Infect Dis; 1997 Dec; 176 Suppl 2():S150-3. PubMed ID: 9396700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current cases in which epitope mimicry is considered a component cause of autoimmune disease: Guillain-Barré syndrome.
    Yuki N
    Cell Mol Life Sci; 2000 Apr; 57(4):527-33. PubMed ID: 11130452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-ganglioside antibody and neuropathy: review of our research.
    Yuki N
    J Peripher Nerv Syst; 1998; 3(1):3-18. PubMed ID: 10959233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of an immunoassay for rapid detection of ganglioside GM(1) mimicry in Campylobacter jejuni strains.
    Prendergast MM; Kosunen TU; Moran AP
    J Clin Microbiol; 2001 Apr; 39(4):1494-500. PubMed ID: 11283076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of antibodies reactive with GM2 ganglioside after immunization with lipopolysaccharides from Camplyobacter jejuni.
    Ritter G; Fortunato SR; Cohen L; Noguchi Y; Bernard EM; Stockert E; Old LJ
    Int J Cancer; 1996 Apr; 66(2):184-90. PubMed ID: 8603809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ganglioside-like epitopes of lipopolysaccharides from Campylobacter jejuni (PEN 19) in three isolates from patients with Guillain-Barré syndrome.
    Yuki N; Handa S; Tai T; Takahashi M; Saito K; Tsujino Y; Taki T
    J Neurol Sci; 1995 May; 130(1):112-6. PubMed ID: 7544402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guillain-Barré syndrome and Fisher's syndrome following Campylobacter jejuni infection.
    Yuki N; Miyatake T
    Ann N Y Acad Sci; 1998 Jun; 845():330-40. PubMed ID: 9668366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.